Pfizer is leaving no stone unturned in its efforts to prevent Novo Nordisk from stealing off with Metsera, the weight-loss therapy developer it is hoping to acquire in a deal worth up to $7.3 billion.

Our two top picks for pain-free tax prep in 2026 face off on ease of use, coverage, support, mobile apps, and more. I write about money. I’ve been reviewing tax software and services as a freelancer ...